276 related articles for article (PubMed ID: 15534907)
1. A novel, rapid strategy to form dendritomas from human dendritic cells and hepatocellular carcinoma cell line HCCLM3 cells using mature dendritic cells derived from human peripheral blood CD14+ monocytes within 48 hours of in vitro culture.
Guan X; Peng JR; Yuan L; Wang H; Wei YH; Leng XS
World J Gastroenterol; 2004 Dec; 10(24):3564-8. PubMed ID: 15534907
[TBL] [Abstract][Full Text] [Related]
2. [Inducing hepatocellular carcinoma-specific cytotoxic T lymphocyte response using formed by fusion of FastDCs and allogeneic human hepatocellular carcinoma cells].
Guan X; Leng XS; Peng JR; Wei YH; Wang H; Yuan L
Zhonghua Yi Xue Za Zhi; 2005 Dec; 85(47):3332-6. PubMed ID: 16409838
[TBL] [Abstract][Full Text] [Related]
3. [Establishment of dendritomas by fusion of human dendritic cells with human hepatocellular carcinoma cell line HLE cells].
Guan X; Peng JR; Leng XS
Zhonghua Zhong Liu Za Zhi; 2005 Aug; 27(8):465-7. PubMed ID: 16188141
[TBL] [Abstract][Full Text] [Related]
4. Mature dendritic cells derived from human monocytes within 48 hours: a novel strategy for dendritic cell differentiation from blood precursors.
Dauer M; Obermaier B; Herten J; Haerle C; Pohl K; Rothenfusser S; Schnurr M; Endres S; Eigler A
J Immunol; 2003 Apr; 170(8):4069-76. PubMed ID: 12682236
[TBL] [Abstract][Full Text] [Related]
5. Feasibility to generate monocyte-derived dendritic cell from coculture with melanoma tumor cells in the presence of granulocyte/macrophage colony-stimulating factor (GM-CSF) and interleukin-4.
Kim YT; Hersh EM; Trevor KT
Am J Reprod Immunol; 2003 Apr; 49(4):230-8. PubMed ID: 12852497
[TBL] [Abstract][Full Text] [Related]
6. Costimulatory function of umbilical cord blood CD14+ and CD34+ derived dendritic cells.
Dilioglou S; Cruse JM; Lewis RE
Exp Mol Pathol; 2003 Aug; 75(1):18-33. PubMed ID: 12834622
[TBL] [Abstract][Full Text] [Related]
7. Generation of dendritic cells from adherent cells of cord blood by culture with granulocyte-macrophage colony-stimulating factor, interleukin-4, and tumor necrosis factor-alpha.
Zheng Z; Takahashi M; Narita M; Toba K; Liu A; Furukawa T; Koike T; Aizawa Y
J Hematother Stem Cell Res; 2000 Aug; 9(4):453-64. PubMed ID: 10982243
[TBL] [Abstract][Full Text] [Related]
8. Dendritomas formed by fusion of mature dendritic cells with allogenic human hepatocellular carcinoma cells activate autologous cytotoxic T lymphocytes.
Chan RC; Xie H; Zhao GP; Xie Y
Immunol Lett; 2002 Sep; 83(2):101-9. PubMed ID: 12067758
[TBL] [Abstract][Full Text] [Related]
9. Function of CD80 and CD86 on monocyte- and stem cell-derived dendritic cells.
Dilioglou S; Cruse JM; Lewis RE
Exp Mol Pathol; 2003 Dec; 75(3):217-27. PubMed ID: 14611813
[TBL] [Abstract][Full Text] [Related]
10. Characterization of canine monocyte-derived dendritic cells with phenotypic and functional differentiation.
Wang YS; Chi KH; Liao KW; Liu CC; Cheng CL; Lin YC; Cheng CH; Chu RM
Can J Vet Res; 2007 Jul; 71(3):165-74. PubMed ID: 17695590
[TBL] [Abstract][Full Text] [Related]
11. [Expression of CC-chemokine ligand 18 (CCL18) in the serum and pleural effusion of non-small-cell lung cancer patients and its regulatory effect on the differentiation of monocyte-derived dendritic cells].
Chen L; Zhou Q; Zhong F; Wang Q; Fang Y; Yang K; Guan S
Zhonghua Zhong Liu Za Zhi; 2014 Nov; 36(11):823-7. PubMed ID: 25620478
[TBL] [Abstract][Full Text] [Related]
12. Differential effects of autologous serum on CD34(+) or monocyte-derived dendritic cells.
Loudovaris M; Hansen M; Suen Y; Lee SM; Casing P; Bender JG
J Hematother Stem Cell Res; 2001 Aug; 10(4):569-78. PubMed ID: 11522239
[TBL] [Abstract][Full Text] [Related]
13. Large-scale immunomagnetic selection of CD14+ monocytes to generate dendritic cells for cancer immunotherapy: a phase I study.
Babatz J; Röllig C; Oelschlägel U; Zhao S; Ehninger G; Schmitz M; Bornhäuser M
J Hematother Stem Cell Res; 2003 Oct; 12(5):515-23. PubMed ID: 14594508
[TBL] [Abstract][Full Text] [Related]
14. Generation of dendritic cells from positively selected CD14+ monocytes for anti-tumor immunotherapy.
Curti A; Isidori A; Ferri E; Terragna C; Neyroz P; Cellini C; Ratta M; Baccarani M; Lemoli RM
Leuk Lymphoma; 2004 Jul; 45(7):1419-28. PubMed ID: 15359643
[TBL] [Abstract][Full Text] [Related]
15. [Generation of CD14+ dendritic cells in vitro with GM-CSF and IL-4].
Guo J; Cai M
Sheng Wu Yi Xue Gong Cheng Xue Za Zhi; 2002 Jun; 19(2):276-9. PubMed ID: 12224299
[TBL] [Abstract][Full Text] [Related]
16. CD14+CD16++ cells derived in vitro from peripheral blood monocytes exhibit phenotypic and functional dendritic cell-like characteristics.
Ancuta P; Weiss L; Haeffner-Cavaillon N
Eur J Immunol; 2000 Jul; 30(7):1872-83. PubMed ID: 10940876
[TBL] [Abstract][Full Text] [Related]
17. Generation of CMRF-44+ monocyte-derived dendritic cells: insights into phenotype and function.
Vuckovic S; Fearnley DB; Mannering SI; Dekker J; Whyte LF; Hart DN
Exp Hematol; 1998 Dec; 26(13):1255-64. PubMed ID: 9845382
[TBL] [Abstract][Full Text] [Related]
18. Induction of specific cytolytic T lymphocytes using fusions of hepatocellular carcinoma (HCC) patient-derived dendritic cells and allogeneic HCC cell line.
Yin XY; Wang L; Lu MD; Li BJ; Huang JF
Hepatogastroenterology; 2008; 55(81):155-9. PubMed ID: 18507097
[TBL] [Abstract][Full Text] [Related]
19. Induction of G250-targeted and T-cell-mediated antitumor activity against renal cell carcinoma using a chimeric fusion protein consisting of G250 and granulocyte/monocyte-colony stimulating factor.
Tso CL; Zisman A; Pantuck A; Calilliw R; Hernandez JM; Paik S; Nguyen D; Gitlitz B; Shintaku PI; de Kernion J; Figlin R; Belldegrun A
Cancer Res; 2001 Nov; 61(21):7925-33. PubMed ID: 11691814
[TBL] [Abstract][Full Text] [Related]
20. [Experimental model of in vitro generation of human dendritic cells].
Oancea C; Jiga J; Tudorache V; Păunescu V; Mihalaş G; Bunu C; Jiga L
Pneumologia; 2007; 56(4):183, 185-9. PubMed ID: 18320793
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
